Form D · Pharmaceuticals

AVALON PHARMACEUTICALS INC

Germantown, MD · CIK 0001162192

Offering snapshot reported Nov 7, 2008 · SEC filing

Reported sold
$237K
Offering amount: $237K
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 7, 2008Initial$237,338No comparisonNot reportedSEC filing
Jun 5, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Feb 6, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Mar 13, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-87613

Source: Form D, filed Nov 7, 2008. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth C. Carter Director, Executive
Philip Frost Director
J. Michael Hamilton Executive
Stephen K. Horrigan Executive
David S. Kabakoff Director
Michael R. Kurman Director
Bradley G. Lorimier Director
William H. Washecka Director
C. Eric Winzer Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
20358 Seneca Meadows Parkway
Germantown, MD, 20876